+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glycopyrrolate"

Peptic Ulcer Global Market Report 2024 - Product Thumbnail Image

Peptic Ulcer Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Peptic Ulcers - Pipeline Review, H1 2020 - Product Thumbnail Image

Peptic Ulcers - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 65 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Glycopyrrolate is a medication used in the treatment of oncology drugs. It is a muscarinic antagonist, meaning it blocks the action of the neurotransmitter acetylcholine in the body. It is used to treat symptoms of overactive bladder, such as frequent urination, urgency, and incontinence. It is also used to reduce excessive saliva production in patients with head and neck cancer. Glycopyrrolate is available in both oral and injectable forms. Glycopyrrolate is used in combination with other drugs to treat certain types of cancer, such as lung cancer, breast cancer, and colorectal cancer. It is also used to reduce the side effects of chemotherapy, such as nausea and vomiting. In addition, it is used to reduce the risk of infection in patients undergoing radiation therapy. Glycopyrrolate is a widely used medication in the oncology drugs market. It is available from a variety of pharmaceutical companies, including Pfizer, Merck, and Bristol-Myers Squibb. Other companies that produce glycopyrrolate include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more